Home Industries Market Insights About Us Publisher Contact us

Preimplantation Genetic Testing Market By Product Type (Reagents & Consumables, Instruments, Software, Services) By End User (Maternity Centers & Fertility Clinics, Hospitals and Diagnostic Laboratories, Research Laboratories & Academic Institutes) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Preimplantation Genetic Testing Market Overview 

The Global Preimplantation Genetic Testing Market size is estimated to reach $598.1 Million by 2026, growing at a CAGR of 11.4% over the forecast period of 2021-2026. Preimplantation genetic testing is a technique for detecting genetic problems in vitro fertilization (IVF) embryos before they are implanted. Preimplantation genetic diagnosis (PGD) is a term used to describe when one or both genetic parents have a known genetic disorder, and testing is done on an embryo to see if it, too, has a genetic defect. Preimplantation genetic screening (PGS), on the other hand, refers to approaches for detecting aneuploidy in embryos from genetic parents who are thought to be chromosomally normal. The rising rate of infertility around the world, the growing number of fertility clinics around the world, public-private investments in the field of preimplantation genetic testing, technological advancements in the field of genetic analysis, and the high risk of chromosomal abnormalities in the foetus with increasing maternal age are all driving this market forward.

 

Impact of COVID-19 on Preimplantation Genetic Testing Market

The COVID-19 pandemic has substantially influenced the genetic testing industry's expansion. To counteract the spread of the SARS-CoV2 virus, most genetic testing facilities have utilized virtualization and home testing kits/home sample collection. However, there was a reported difficulty in obtaining genetic testing blood draws, which significantly influenced genetic testing. As a result, during the current crisis, COVID-19 is likely to, directly and indirectly, influence the genetic testing business.

 

Key Takeaways from Global Preimplantation Genetic Testing Market Report:

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for a product, end-use, technology and by different industry verticals. Understand the different market dynamics – key driving factors, challenges, and hidden opportunities.
  • Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than the top 20 countries globally for the market.

 Preimplantation Genetic Testing Market

By Product, the reagents & consumables segment market is estimated to grow at the highest CAGR during the forecast period.

Due to increased application frontiers of specialized technologies, the reagents & consumables category accounted for the biggest market share by Product & service (such as NGS and aCGH for whole-genome sequencing and FISH in the diagnosis of specific genetic disorders). It is also the fastest-growing, with a CAGR of 11.9% over 2021-2026.

 

By application, the aneuploidy segment held the largest share during the forecast period.

Factors such as increasing maternal age and the rising incidence of aneuploidy have led to the growth of this segment. Among end-users, the maternity centers & fertility clinics segment accounted for the largest share and is also set to be fastest growing with a CAGR of 12.1% over the period 2021-2026 for the global preimplantation genetic testing market due to factors such as the increasing number of fertility centers and the high treatment success rate at such centers.

 

The Asia Pacific to account for the largest market share during the forecast period

North America holds the highest proportion of the worldwide market, with a share of 37.6% in 2020 for preimplantation genetic testing. The increased number of IVF treatments (with declining conception rates), widespread acceptance of genomic methods, and the continued trend of replacing old genomic technologies with sophisticated and creative genetic techniques are all factors contributing to North America's big share (such as FISH and NGS). Because of the rising focus of players on emerging markets and improvements in healthcare infrastructure in these countries, the Asia-Pacific region is predicted to expand at the fastest rate throughout the projection period.

 

Market Dynamics

Driver: Rising infertility in the world is a key driver in Preimplantation Genetic Testing

Infertility and complications of infertility, such as miscarriages, can negatively impact a person's general health and quality of life. Many couples who wish to establish a family but cannot do so may face psychological and interpersonal pain, lowering their quality of life. As per CDC in the U.S., 12% of women of childbearing age have used services for infertility.

 

Challenge: The high procedure costs connected with preimplantation genetic testing and unsupportive government laws are limiting the market's expansion.

 

Key Market Players   

Key Players in the Global Preimplantation Genetic Testing Market consist of Illumina, Inc.*, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., PerkinElmer, Inc. , CooperSurgical, Inc. , Beijing Genomics Institute (BGI), Abbott Laboratories , Natera Inc. , Genea Limited, Rubicon Genomics, Inc. , and Oxford Gene Technology.

 

Developments

There have been no developments in the Preimplantation Genetic Testing Market in the last 5 years.

 

Report Coverage and Scope

The report "Global Preimplantation Genetic Testing Market" by Research Informatic covers an in-depth detailed analysis for the following segment, covered under the scope.

 

By Product

  • Reagents & Consumables
  • Instruments
  • Software
  • Services

 

By End Users

  • Maternity Centers & Fertility Clinics
  • Hospitals and Diagnostic Laboratories
  • Research Laboratories & Academic Institutes

 

By Applications

  • Aneuploidy
  • Structural Chromosomal abnormalities
  • Single gene disorders
  • X-linked disorders
  • HLA Typing
  • Gender Identification

 

By Technology

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescent In-Situ Hybridization (FISH)
  • Comparative Genomic Hybridization (CGH)
  • Single Nucleotide Polymorphism (SNP)

 

Geography

  • North America
  • Europe
  • APAC
  • RoW

 

 

 


Chapter 1 Preimplantation Genetic Testing Market Overview


1.1 Product Overview and Scope of Preimplantation Genetic Testing


1.2 Preimplantation Genetic Testing Market Segmentation By Product Type


1.2.1 Reagents & Consumables


1.2.2 Instruments


1.2.3 Software


1.2.4 Services


1.3 Preimplantation Genetic Testing Market Segmentation By End User


1.3.1 Maternity Centers & Fertility Clinics


1.3.2 Hospitals and Diagnostic Laboratories


1.3.3 Research Laboratories & Academic Institutes


1.4 Preimplantation Genetic Testing Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Preimplantation Genetic Testing (2015-2027)


 


Chapter 2 Global Economic Impact on Preimplantation Genetic Testing Industry


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Preimplantation Genetic Testing Market Competition by Manufacturers


3.1 Global Preimplantation Genetic Testing Production and Share by Manufacturers (2021 and 2021)


3.2 Global Preimplantation Genetic Testing Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Preimplantation Genetic Testing Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Preimplantation Genetic Testing Manufacturing Base Distribution, Production Area and Product Type


3.5 Preimplantation Genetic Testing Market Competitive Situation and Trends


3.5.1 Preimplantation Genetic Testing Market Concentration Rate


3.5.2 Preimplantation Genetic Testing Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


Chapter 4 Global Preimplantation Genetic Testing Production, Revenue (Value) by Region (2015-2021)


4.1 Global Preimplantation Genetic Testing Production by Region (2015-2021)


4.2 Global Preimplantation Genetic Testing Production Market Share by Region (2015-2021)


4.3 Global Preimplantation Genetic Testing Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Preimplantation Genetic Testing Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Preimplantation Genetic Testing Supply (Production), Consumption, Export, Import by Regions (2015-2021)


5.1 Global Preimplantation Genetic Testing Consumption by Regions (2015-2021)


5.2 North America Preimplantation Genetic Testing Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Preimplantation Genetic Testing Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Preimplantation Genetic Testing Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Preimplantation Genetic Testing Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Preimplantation Genetic Testing Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Preimplantation Genetic Testing Production, Consumption, Export, Import by Regions (2015-2021)


 


Chapter 6 Global Preimplantation Genetic Testing Production, Revenue (Value), Price Trend by Type


6.1 Global Preimplantation Genetic Testing Production and Market Share by Type (2015-2021)


6.2 Global Preimplantation Genetic Testing Revenue and Market Share by Type (2015-2021)


6.3 Global Preimplantation Genetic Testing Price by Type (2015-2021)


6.4 Global Preimplantation Genetic Testing Production Growth by Type (2015-2021)


 


Chapter 7 Global Preimplantation Genetic Testing Market Analysis by Application


7.1 Global Preimplantation Genetic Testing Consumption and Market Share by Application (2015-2021)


7.2 Global Preimplantation Genetic Testing Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Preimplantation Genetic Testing Manufacturing Cost Analysis


8.1 Preimplantation Genetic Testing Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Nano Diamond Battery


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


9.1 Preimplantation Genetic Testing Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Preimplantation Genetic Testing Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Preimplantation Genetic Testing Market Forecast (2021-2027)


12.1 Global Preimplantation Genetic Testing Production, Revenue Forecast (2021-2027)


12.2 Global Preimplantation Genetic Testing Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Preimplantation Genetic Testing Production Forecast by Type (2021-2027)


12.4 Global Preimplantation Genetic Testing Consumption Forecast by Application (2021-2027)


12.5 Preimplantation Genetic Testing Price Forecast (2021-2027)


 


Chapter 13 Appendix    


 


 


 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Preimplantation Genetic Testing?

Preimplantation genetic testing is a technique for detecting genetic problems in vitro fertilization (IVF) embryos before they are implanted. Preimplantation genetic diagnosis (PGD) is a term used to describe when one or both genetic parents have a known genetic disorder, and testing is done on an embryo to see if it, too, has a genetic defect.

What is the Preimplantation Genetic Testing market share?

The Global Preimplantation Genetic Testing Market size is estimated to reach $598.1 Million by 2026, growing at a CAGR of 11.4% over the forecast period of 2021-2026.

What are the key factors driving the Preimplantation Genetic Testing Market?

Rising infertility in the world is a key driver in Preimplantation Genetic Testing market. Infertility and complications of infertility, such as miscarriages, can negatively impact a person's general health and quality of life.

What are the top companies in the Preimplantation Genetic Testing Market?

Illumina, Inc.*, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., PerkinElmer, Inc. , CooperSurgical, Inc. , Beijing Genomics Institute (BGI), Abbott Laboratories , Natera Inc. , Genea Limited, Rubicon Genomics, Inc. , and Oxford Gene Technology.

In which Region the market is growing?

North America holds the highest proportion of the worldwide market, with a share of 37.6% in 2020 for preimplantation genetic testing.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Preimplantation Genetic Testing Market By Product ...

RD Code : HP22